CryoPort Quarterly Cash Flow Statement
NASDAQ: CYRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
17.35+0.45 (+2.66%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
CryoPort free cash flow
In the quarter ended Jun 30, 2026, CryoPort generated $1.1 million of operating cash flow and spent $9.1 million on capital expenditures. That left free cash flow of -$8.0 million, a free-cash-flow margin of -16.3% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
CryoPort cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -8.26M | -10.54M | -11.64M | -6.94M | 108.87M | -11.98M | -18.68M | 805.00K | -77.99M | -18.89M | -62.39M | -13.27M |
| Net Income growth (YoY) | -107.58% | — | — | -962.48% | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 6.59M | 6.40M | 6.36M | 6.42M | 7.30M | 7.65M | 7.89M | 7.84M | 7.56M | 7.47M | 7.45M | 6.91M |
| Stock-Based Compensation | 2.40M | 2.40M | 2.43M | 2.53M | 2.04M | 3.06M | 3.64M | 4.06M | 4.20M | 4.67M | 2.86M | 5.98M |
| Change in Working Capital | 2.18M | 4.33M | -4.51M | 552.00K | 1.44M | -2.00M | 923.00K | 1.15M | -1.89M | 665.00K | 2.25M | -383.00K |
| Operating Cash Flow | 1.13M | 3.73M | 919.00K | 2.19M | -7.34M | -4.34M | -5.48M | 447.00K | -8.03M | -3.27M | 2.48M | -1.96M |
| Capital Expenditures | -9.10M | -9.98M | -5.47M | -3.45M | -4.35M | -3.17M | -5.22M | -4.24M | -3.79M | -4.01M | -11.57M | -8.97M |
| Investing Cash Flow | -5.81M | 18.72M | 56.00K | 14.31M | 230.04M | 5.92M | 3.48M | 153.57M | 13.32M | 6.45M | -14.76M | 18.51M |
| Share Repurchases | — | — | -2.01M | -3.75M | — | — | — | — | — | — | — | — |
| Debt Repaid | — | — | — | — | — | — | 0 | -155.11M | — | — | 0 | — |
| Financing Cash Flow | 653.00K | 85.00K | -2.15M | -2.87M | -15.86M | -189.00K | 2.01M | -155.29M | -8.76M | 512.00K | -126.00K | -24.89M |
| Net Change in Cash | -3.65M | 22.42M | -5.32M | 12.39M | 196.06M | 2.07M | 624.00K | -1.79M | -3.21M | 3.32M | -13.13M | -7.84M |
| Free Cash Flow | -7.97M | -6.25M | -4.55M | -1.26M | -11.70M | -7.51M | -10.70M | -3.79M | -11.81M | -7.27M | -9.09M | -10.93M |
This table shows 12 quarterly periods of CryoPort's cash flow statement, from Q2 2026 back to Q3 2023, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow CYRX's reporting calendar. What is a cash flow statement?